OKTA vs SABSW · P/E 84, rev $1.57B vs P/E 0.0
Okta Inc (OKTA) versus SAB Biotherapeutics Inc (SABSW) — a side-by-side from cached financials, not a winner call.
Okta Inc (OKTA) is a software - infrastructure company listed on NASDAQ.
SAB Biotherapeutics Inc (SABSW) common stock listed on NASDAQ.
Latest reported OKTA revenue for 2026-07-31 was $1.57B. Net income was $190.0M. OKTA currently screens at market cap $20.06B and trailing P/E 83.6.
SABSW does not have a complete income-statement cache yet.
OKTA currently screens at market cap $20.06B and trailing P/E 83.6. SABSW currently screens at market cap $0 and trailing P/E 0.0.
Not investment advice. Open the OKTA and SABSW stock pages for the full models.
Not investment advice.